Recently, researchers from 28 medical and research institutions across India have established the country's first government-supported national biobank dedicated to Lysosomal Storage Disorders (LSDs). This initiative is crucial as it aims to enhance the development of affordable diagnostic tools and treatments for children suffering from these severe genetic conditions.
This topic holds significance for UPSC aspirants due to its relevance in both Prelims and Mains examinations:
UPSC aspirants should study this topic to understand the intersection of healthcare innovation and policy-making in India.
Lysosomal Storage Disorders are a group of over 70 rare genetic disorders caused by enzyme deficiencies, leading to the accumulation of fats and sugars within cells. This accumulation results in progressive organ damage, severely affecting the quality of life. In India, over 12,000 individuals are believed to suffer from these disorders, with available treatment options often prohibitively expensive, exceeding Rs 1 crore annually for enzyme replacement therapies.
In the Prelims, candidates may be asked to identify facts about the biobank, such as its purpose and the types of disorders it addresses. In contrast, Mains questions could explore the implications of establishing such a biobank on public health policy, the economic burden of rare diseases, and the potential for indigenous therapy development.
The establishment of the biobank represents a significant advancement in the research of rare diseases in India. By centralising biological samples and clinical data, it addresses the historical lack of coordinated research efforts in this domain. This initiative is expected to enhance early diagnosis, foster the development of cost-effective therapies, and ultimately improve healthcare outcomes for affected families.
The biobank initiative marks a critical step towards strengthening India's rare disease research ecosystem. By focusing on sustainability and evidence-based policy, this project could pave the way for better management of rare diseases. It is anticipated to foster resilience in healthcare systems and ensure more equitable access to treatments for all affected individuals.
Q1. What are Lysosomal Storage Disorders?
Answer: Lysosomal Storage Disorders (LSDs) are a group of inherited metabolic diseases caused by enzyme deficiencies, leading to harmful substance accumulation in cells.
Q2. What is the purpose of the national biobank in India?
Answer: The biobank aims to consolidate biological samples and clinical data to facilitate research and development of affordable treatments for LSDs.
Q3. How does the biobank contribute to rare disease research?
Answer: By centralising data and samples, the biobank enhances research capabilities, enabling better diagnosis and therapy development for rare diseases.
Q4. What role does the Department of Biotechnology play in the biobank initiative?
Answer: The Department of Biotechnology finances the biobank, supporting biomedical research to address rare diseases in India.
Q5. Why are treatments for LSDs often expensive?
Answer: Treatments for LSDs typically require enzyme replacement therapies, which are complex to produce and can cost over Rs 1 crore annually per patient.
Question 1: What is the primary objective of the national biobank for LSDs in India?
A) To provide free treatments
B) To collect biological samples and clinical data
C) To create awareness about rare diseases
D) To eliminate all rare diseases
Correct Answer: B
Question 2: Which organization leads the initiative of the national biobank for LSDs?
A) Tata Institute of Fundamental Research
B) Foundation for Research in Genetics and Endocrinology
C) Indian Council of Medical Research
D) National Institute of Health
Correct Answer: B
Question 3: How many patients' data are integrated into the national biobank?
A) 250
B) 530
C) 1000
D) 1500
Correct Answer: B
Question 4: What is a significant challenge in treating patients with LSDs?
A) Lack of awareness
B) High treatment costs
C) Availability of medications
D) Limited research
Correct Answer: B
Kutos : AI Assistant!
